Drugs / QBKPN SSI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02256852 | Dec 2014 → Nov 2015 | non-small cell lung carcinoma | Qu Biologics Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QBKPN SSI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02256852 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT02256852 ↗ |